Liquid-based cytology (smear analysis)
This guide explains liquid-based cytology — the modern way a cervical screening sample is processed and examined in the laboratory — and what your result means.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Liquid-based cytology is the laboratory method for preparing and examining a cervical screening sample collected into a pot of liquid.
- It lets the same sample be tested for high-risk HPV first, with the cells examined only if HPV is found.
- It has reduced the number of inadequate samples compared with the older slide method, but no screening test is perfect.
- It does not change what screening can do: it checks for cervical cell changes, not for womb or ovarian cancer, and symptoms still need separate assessment.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Produces a cleaner sample with fewer cells obscured by blood or mucus.
It is not the right test if you have symptoms such as unusual bleeding — symptoms need a separate assessment.
Cells are collected into liquid and sent to the laboratory. You can usually return to your normal day; some people notice light spotting.
A clear result letter that explains what was found and what to do next.
Cells are collected into liquid and sent to the laboratory. You can usually return to your normal day; some people...
The laboratory tests the liquid for high-risk HPV, and prepares a thin layer of cells for examination only if HPV...
Your result is usually sent to you by letter, and to your GP.
You are referred for colposcopy, usually within a few weeks. Most people who have colposcopy do not have cancer.

What is liquid-based cytology?
Liquid-based cytology (LBC) is the modern way that a cervical screening sample is prepared and examined. At your screening appointment, cells are collected from the cervix and rinsed into a small pot of liquid rather than being smeared onto a glass slide. In the laboratory, the liquid is processed to give a clean, thin layer of cells that is easier to test and examine.
You do not have anything extra done to you for this. The sample has already been taken. This guide is about what happens to your sample in the laboratory and what your result means.
LBC is the method used in the NHS Cervical Screening Programme. It allows the same sample to be tested first for high-risk human papillomavirus (HPV), and then, only if HPV is found, examined under the microscope for cell changes (cytology). Since LBC was introduced, fewer samples have to be rejected as inadequate compared with the older slide method.
LBC is a way of handling and reading the sample — it does not change what screening can do. Screening checks for cell changes that could lead to cervical cancer; it is not a test for cancer itself and does not check for womb or ovarian cancer.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Liquid-based cytology vs the older smear method
| Feature | Liquid-based cytology | Older glass-slide smear |
|---|---|---|
| How the sample is stored | Rinsed into liquid | Smeared onto a slide |
| Inadequate samples | Fewer | More common |
| HPV test from same sample | Yes | Not designed for it |
| Cells obscured by blood/mucus | Often reduced | More likely |
Both methods examine cells from the cervix. LBC is now the standard NHS method; it improves sample handling but does not change what screening can and cannot detect.
Preparing for your test
- There is nothing extra to prepare for the laboratory processing — the sample is taken at your screening appointment.
- Try to book your screening when you are not having a period, as blood can affect the sample.
- Tell the sample-taker about any symptoms such as unusual bleeding or discharge, as screening is not the right test for symptoms.
- Mention any previous abnormal results or treatment, as these may change your follow-up.
- Note when and how you will get your result (usually a letter within about 2 weeks).
- Keep attending when invited, even if you feel well and have had the HPV vaccine.
What happens
At your appointment, a small brush collects cells from the cervix, and the brush is rinsed into a pot of liquid that is sent to the laboratory.
The laboratory first tests the liquid for high-risk HPV. If no high-risk HPV is found, the cells are not examined further and you return to routine screening. If high-risk HPV is found, the liquid is processed to produce a clean, thin layer of cells on a slide, which a specialist examines under the microscope for any changes.
The laboratory then issues a result, which is sent to you, usually by letter, and to your GP. If a closer look is needed, you are referred for colposcopy.
Is this test right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- It is not the right test if you have symptoms such as unusual bleeding — symptoms need a separate assessment.
- It does not check for womb, ovarian, vulval or other gynaecological cancers.
- It is not designed for those outside the programme's age range or for diagnosing an existing problem.
- It cannot give a reliable result from an inadequate sample, which must be repeated.
Delay or rearrange if…
- You are having a period, as blood can make the sample harder to read.
- You have symptoms that need urgent assessment, which should come first.
- You have recently had treatment to the cervix and are within the advised waiting period.
- You are pregnant and screening can usually be safely deferred — check with your clinician.
Alternatives to discuss
- Following the routine NHS screening interval rather than testing more often.
- Prompt assessment by a GP or gynaecologist if you have symptoms.
- Colposcopy and biopsy when cell changes need a closer look or a tissue diagnosis.
- HPV vaccination to reduce the risk of cell changes, alongside (not instead of) screening.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Produces a cleaner sample with fewer cells obscured by blood or mucus.
- Reduces the number of inadequate samples that have to be repeated.
- Allows HPV testing and cell examination from a single sample.
- Makes the cells easier and quicker for the laboratory to examine.
- Supports the HPV-first screening pathway used across the NHS.
- A clear, low-risk result is reassuring and means routine recall.
Risks & complications
- Waiting for the result letter can be worrying.
- An 'HPV found' result can be upsetting, though HPV is common and usually clears on its own.
- A sample can still occasionally be inadequate and need repeating.
- Like all cervical screening, it does not check for womb, ovarian or other cancers.
- A false-positive result, where cells look abnormal but the cervix is normal, leading to further tests.
- A false-negative result, where changes are missed, which is one reason screening is repeated.
- Referral to colposcopy and possible biopsy or treatment, with their own discomfort and small risks.
- Treatment of cell changes can, in some people, affect future pregnancies, which should be discussed first.
- Very occasionally a sample is lost or has to be repeated for laboratory reasons.
Liquid-based cytology improves how the sample is handled but does not make screening perfect, and it is not a test for cancer or for womb or ovarian cancer. If you have symptoms such as bleeding between periods, after sex or after the menopause, see your GP rather than waiting for your next screen, because symptoms need a different assessment.
Published figures to discuss
The proportion of inadequate samples is lower with liquid-based cytology than with the older slide method, and most reported inadequate rates are low. False-positive and false-negative results still occur, and exact figures vary by laboratory and population. We avoid quoting precise percentages here; the key points are that LBC improves sample handling but does not make screening perfect, and that symptoms always need separate assessment.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| High-risk HPV positive result | Common | Most HPV infections clear; screening pathways use HPV and cytology to decide recall or colposcopy. | Evaluation of liquid-based cytology and HPV testing in UK screening (PMC)ncbi.nlm.nih.govSource-linked context |
| False negative screening result | Recognised | Symptoms such as postcoital bleeding or persistent abnormal bleeding need assessment regardless of screening history. | Evaluation of liquid-based cytology and HPV testing in UK screening (PMC)ncbi.nlm.nih.govSource-linked context |
| Inadequate sample | Uncommon but expected | A repeat sample may be needed if the lab cannot report it reliably. | Guide sourcesClinical context |
| Overdiagnosis anxiety | Screening trade-off | Screening mainly detects risk and pre-cancer, not usually cancer; follow-up prevents harm. | Evaluation of liquid-based cytology and HPV testing in UK screening (PMC)ncbi.nlm.nih.govSource-linked context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no physical recovery from the laboratory processing, because the sample has already been taken at your screening appointment. The main thing afterwards is waiting for your result letter and understanding what it means.
- Light spotting for a day or so after the sample is taken.
- Feeling anxious while you wait for your result letter.
- Being asked to repeat the test after about 3 months if the sample was inadequate.
- Being invited back in 12 months if HPV is found but the cells look normal.
Aftercare
- Read your result letter carefully and follow the instructions it gives.
- If you do not receive a result within a few weeks, contact your GP to check.
- Attend any repeat screen or colposcopy appointment you are offered.
- See your GP about any unusual bleeding or discharge, even with a normal screen.
- Keep attending future screening invitations up to the programme's upper age.
- Ask your GP or clinic to explain anything in your letter you do not understand.
- Booked screening when not on your period
- Mentioned any symptoms to the sample-taker
- Noted when your result letter should arrive
- Kept a record of previous results or treatment
- Saved your GP's number to chase results if needed
- Diarised any repeat or colposcopy appointment
⚠ Get urgent help if…
- Bleeding between periods, after sex, or any bleeding after the menopause
- A persistent or unusual change in vaginal discharge
- Persistent pelvic pain or pain during sex
- Unexplained weight loss with gynaecological symptoms
- Heavy bleeding or signs of infection after a colposcopy biopsy or treatment
- Any symptom that worries you, even if your last screening result was normal
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good result clearly states whether high-risk HPV was found and, if it was, whether any cell changes were seen and what should happen next. The most common results are reassuring, with HPV not found and a return to routine screening.
Using liquid-based cytology does not change what the result can prove. It cannot guarantee you will never develop cervical cancer, and it does not check for womb or ovarian cancer. Screening lowers risk over time rather than removing it, which is why repeat screening matters and why symptoms always need separate assessment.
A screening result reflects the sample at the time it was taken. A clear, HPV-negative result usually means routine recall over the next few years; an HPV-positive result usually means earlier repeat testing. Because HPV status and cell changes can change over time, screening is repeated rather than being a single test for life.
Related tests, treatments or support
Liquid-based cytology is part of the same pathway as the HPV test, which is performed first on the same liquid sample. If cell changes are found, colposcopy and a possible tissue sample (biopsy) follow, and that biopsy is examined by a pathologist. Screening sits alongside HPV vaccination, which reduces the risk of cell changes.
Follow-up & long-term care
Your result is sent to you and your GP. If HPV is found with cell changes you are referred for colposcopy; if HPV is found without changes you are usually re-tested in about 12 months; if no HPV is found you return to routine recall. After two inadequate samples you may also be referred for colposcopy. Your letter will tell you which applies.
- Attend cervical screening whenever you are invited, up to the programme's upper age.
- Keep your contact details up to date with your GP so invitations reach you.
- Report unusual symptoms promptly rather than waiting for the next screen.
- Follow any earlier recall arranged after an HPV-positive or abnormal result.
Repeat, follow-on and what comes next
- An inadequate sample usually needs to be repeated, often after about three months.
- An HPV-positive result with normal cells usually means a repeat screen in about 12 months.
- Cell changes seen on cytology are usually re-checked at colposcopy with a tissue biopsy before any treatment.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear result letter that explains what was found and what to do next.
- An easy way to ask questions and to chase the result if it does not arrive.
- Prompt referral to colposcopy when needed, with clear information about it.
- Advice to report symptoms between screens rather than waiting for the next invitation.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Whether you use the free NHS programme or pay for a private test.
- Whether HPV testing, cytology, or both are carried out on the sample.
- The clinic or appointment fee for taking the sample privately.
- Any follow-up consultation to explain the result.
- Onward costs if colposcopy, biopsy or treatment is needed.
- Whether a repeat sample is required because the first was inadequate.
- The fee for the appointment and for taking the sample.
- The laboratory fee for HPV testing and/or liquid-based cytology.
- Whether a follow-up consultation to explain results is included.
- What happens, and who pays, if the sample is inadequate and must be repeated.
- The pathway, and any cost, if you are referred for colposcopy.
- How and when your result will be given to you and your GP.
On the NHS? Liquid-based cytology is the standard method in the free NHS Cervical Screening Programme; private testing is available but should follow the programme's recommended timing rather than replace it.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Believing a normal screen rules out all gynaecological cancers, including womb and ovary.
- Using screening to investigate symptoms instead of seeing a doctor.
- Not understanding that an HPV-positive result is common and not the same as cancer.
- Having treatment for cell changes without discussing possible effects on future pregnancies.
Marketing red flags
- Suggesting a newer cytology method can detect cancers screening is not designed to find.
- Encouraging more frequent screening than the programme recommends.
- Implying the HPV vaccine removes the need for screening.
- Promising a smear can 'rule out cancer' completely.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- What exactly does my result mean, and what should happen next?
- If HPV was found, when will I be re-tested or seen for colposcopy?
- What happens if my sample is inadequate or the result is inconclusive?
- I have symptoms — is screening the right test, or do I need a different assessment?
- If I am referred for colposcopy, what does it involve and what are the risks of any treatment?
- How does this result affect when I should next be screened?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my test, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this test not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Is liquid-based cytology better than the old smear?
Will my cells always be examined under the microscope?
Why was my sample still inadequate with this method?
Does this test check for ovarian or womb cancer?
Can I have liquid-based cytology privately?
How often will I be invited for cervical screening?
Who looks at my sample?
Find a verified specialist for liquid-based cytology (smear analysis)
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: NHS — Cervical screening NHS England — Your guide to NHS cervical screening GOV.UK — Cervical screening: understanding test results GOV.UK — Guidance for laboratories providing HPV testing and cytology Cancer Research UK — About cervical screening Evaluation of liquid-based cytology and HPV testing in UK screening (PMC) NHS — Cervical screening: when you'll be invited (England) NHS inform — Cervical screening (Scotland) Public Health Wales — Cervical screening FAQs nidirect — Cervical screening (Northern Ireland)
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Cervical and gynaecological cell testing (cytology) · Immunohistochemistry testing (IHC) · Biopsy analysis (tissue diagnosis) · Bone marrow biopsy reporting · Cancer staging and grading report